Preface

This book covers basic of biostatistics through the Statistical Analysis System (SAS®) which is widely used in Clinical Trial Industry. The book guides the readers on which statistical method is appropriate, and how to implement it correctly inside the specific, standardized, heavily regulated data ecosystem that clinical trials actually run on.
Statistical analysis and clinical data programming are fundamentally interdependent disciplines. A rigorously derived statistical model that cannot be successfully implemented, validated, and traced back to its originating data within a standard Study Data Tabulation Model (SDTM), Analysis Data Model (ADaM), and Tables, Listings, and Figures (TLF) pipeline remains, in practice, incomplete. Conversely, a programmer fluent in Base SAS who lacks comprehension of the underlying statistical rationale risks producing incorrect outputs with unwarranted precision. This volume proceeds from the premise that these two competencies must be unified within a single pedagogical framework, reflecting the integrated nature of professional practice.
Intended Audience
This text addresses three primary readerships:
Early-Career Biostatisticians: Individuals seeking a cohesive pathway connecting foundational statistical theory to industry-specific data standards and reporting frameworks.
Transitioning SAS Programmers: Programmers entering the pharmaceutical domain who require mastery of both statistical reasoning and the CDISC ecosystem (SDTM, ADaM, and TLFs)

Practicing Professionals: Specialists proficient in one domain—either quantitative methodology or SAS-CDISC mechanics—seeking to master the complementary discipline through structured cross-references.
While prior coursework in statistics or SAS programming is not required, readers should possess a foundation in basic algebra and a commitment to executing practical code. All analytical methods are demonstrated using functional, executable SAS syntax rather than pseudocode, employing the specific procedures and DATA step logic required in production environments.
Book Architecture
The volume is organized into six progressive sections:
Part I (Chapters 1–4): Establishes SAS mechanics, data preparation, exploratory data analysis, and fundamental probability.
Part II (Chapters 5–9): Addresses diagnostic procedures, confidence intervals, hypothesis testing, nonparametric methods, and categorical data analysis.
Part III (Chapters 10–15): Explores analysis of variance (ANOVA) and generalized regression frameworks, including linear, logistic, ordinal, and count-outcome models.
Part IV (Chapters 16–20): Covers survival analysis, longitudinal data analysis, statistical power, causal inference, and meta-analysis.
Part V (Chapters 21–34): Forms the clinical trial core, detailing CDISC standards, SDTM architecture, the sequential construction of ADaM datasets, and the generation of submission-ready TLF packages.

Part VI (Chapters 35–37): Examines validation protocols, quality control, professional ethics, and a comprehensive capstone project integrating all preceding methodologies.
Parts I through IV may be studied independently for statistical training, whereas Part V builds directly upon this quantitative foundation to construct clinical data infrastructure. Part VI synthesizes these elements through comprehensive application. Readers with advanced statistical backgrounds are encouraged to review Parts II through IV prior to engaging Part V, as subsequent chapters rely on established concepts such as the t-distribution, logit link functions, and censoring conventions.
Software Environment and Standards
All programming examples are compatible with Base SAS and SAS Studio environments, requiring no specialized third-party add-ons. Because CDISC standards, MedDRA, and the WHO Drug Dictionary are subject to periodic revision, the text emphasizes core structural principles rather than version-specific syntax. Readers must verify current controlled terminology and dictionary requirements for their specific regulatory submissions.